The Global Impact of Endoscopic Ultrasound (EUS) Regarding the Survival of a Pancreatic Adenocarcinoma in a Tertiary Hospital

Abstract

A biliopancreatic EUS carried out during the 2 months prior to the start of the treatment of the pancreatic ductal adenocarcinoma has a statistically significant impact on the patient survival rate. We believe that this is due to the possibility of a very-early-stage diagnosis of the adenocarcinoma permitted by the use of this technique.

Changing trends in tissue acquisition in malignant pancreatic neoplasms

“…These advances in tissue procurement and diagnosis have resulted in improved patient survival in pancreatic cancer. 2,3 In a population-based study of more than 8000 patients with pancreatic cancer, the median survival time for patients who underwent staging by EUS evaluation was significantly longer than those without EUS evaluation. 3 This is because an accurate diagnosis facilitates early initiation of appropriate therapy which in turn favorably impacts patient survival.…”